Holen Sie sich die Stockscreener-App
119.86
1.60%
-2.215
Schlusskurs vom Vortag:
$122.07
Offen:
$123.99
24-Stunden-Volumen:
184.83K
Relative Volume:
0.29
Marktkapitalisierung:
$5.00B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-127.51
EPS:
-0.94
Netto-Cashflow:
-
1W Leistung:
-2.29%
1M Leistung:
+31.01%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$118.20
$125.20
1-Wochen-Bereich:
$118.20
$131.24
52-Wochen-Spanne:
$32.00
$131.24
Veradermics Inc Stock (MANE) Company Profile
Firmenname
Veradermics Inc
Sektor
Branche
Telefon
228.372.3376
Adresse
470 JAMES STREET, NEW HAVEN
Compare MANE vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MANE
Veradermics Inc
|
119.66 | 5.42B | 0 | 0 | 0 | -0.94 |
VRTX
Vertex Pharmaceuticals Inc
|
523.88 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.87 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
921.67 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.22 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.59 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Veradermics Inc Stock (MANE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-03-02 | Eingeleitet | Citigroup | Buy |
| 2026-03-02 | Eingeleitet | Jefferies | Buy |
| 2026-03-02 | Eingeleitet | Leerink Partners | Outperform |
Veradermics Inc Aktie (MANE) Neueste Nachrichten
Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom - BioSpace
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Index - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Value Benchmark - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 2000 Growth Benchmark - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 3000E Growth Benchmark - marketscreener.com
2026 Power 25 Healthcare: Dr. Reid Waldman - Hartford Business Journal
Veradermics, Incorporated(NYSE: MANE) added to Russell Small Cap Completeness Index - marketscreener.com
Veradermics, Incorporated(NYSE: MANE) added to Russell 3000E Index - marketscreener.com
Veradermics, Incorporated Actuals & Estimates (NYSE:MANE) - TradingView
Cantor Fitzgerald reiterates Veradermics stock rating after CEO dinner By Investing.com - Investing.com Australia
MANE Forecast — Price Target — Prediction for 2027 - TradingView
Cantor Fitzgerald reiterates Veradermics stock rating after CEO dinner - Investing.com
MANE Stock Pops As Traders Hunt Biotech Momentum - StocksToTrade
Can Veradermics (MANE) Climb 27.65% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135 - Moomoo
Veradermics, Incorporated(NYSE: MANE) added to S&P Global BMI Index - marketscreener.com
Veradermics, Incorporated(NYSE:MANE) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now? - Yahoo Finance
MANEVeradermics Inc Forecast, Target Price - Finviz
Veradermics Incorporated (MANE) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
BHVN,MANE Forecast, Target Price - Finviz
Analysts Offer Insights on NA Companies: Sunbelt Rentals Holdings Inc (SUNB), Veradermics, Incorporated (MANE) and JBS (JBS) - The Globe and Mail
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $138 - Moomoo
LifeSci Capital Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $135 - Moomoo
Veradermics Company Profile & Introduction - Moomoo
MANE: Extended-release oral minoxidil shows promise for rapid, consistent hair growth in large, underserved markets - TradingView
Total liabilities of Veradermics, Incorporated – BX:MANE - TradingView
Number of shareholders of Veradermics, Incorporated – BX:MANE - TradingView
MANE Technical Analysis | Trend, Signals & Chart Patterns | VERADERMICS INC (NYSE:MANE) - ChartMill
Hot Picks: Biotech rebound driven by innovation and drug pipelines - BNN Bloomberg
Veradermics (MANE) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Needham Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $136 - Moomoo
Two biotech leaders join Achieve Life's new quitting drug push - Stock Titan
This New Hair-Loss Drug Could Be the Biggest Breakthrough in Decades - Cosmopolitan
Veradermics to Present at Upcoming June 2026 Investor Conferences - BioSpace
Veradermics to Present at Upcoming June Investor Conferences - Business Wire
Veradermics to Present VDPHL01 Phase 2/3 ‘302’ Study Results at 2026 World Congress for Hair Research - geneonline.com
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research - BioSpace
Veradermics to present hair loss drug trial data on Friday - Investing.com
Veradermics to present hair loss drug trial data on Friday By Investing.com - Investing.com Canada
New oral drug shows success in reversing hair loss - Fast Company
10 Best Performing NYSE Stocks So Far in 2026 - Insider Monkey
Viking Stake In Veradermics Highlights Risky Growth And Ownership Shifts - Yahoo Finance
Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026 - Insider Monkey
Veradermics Is Maintained at Buy by Citigroup - Moomoo
Veradermics Price Target Raised to $135.00/Share From $120.00 by Citigroup - Moomoo
SR ONE CAPITAL MANAGEMENT, LP's Veradermics Inc(MANE) Holding History - GuruFocus
Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $135 - Moomoo
Viking Global-affiliates hold 1.69M Veradermics shares (MANE) - Stock Titan
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO - Yahoo Finance
Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $138 - Moomoo
Finanzdaten der Veradermics Inc-Aktie (MANE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veradermics Inc-Aktie (MANE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Feb 05 '26 |
Buy |
37.99 |
96,200 |
3,655,079 |
489,932 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Feb 06 '26 |
Buy |
36.34 |
30,521 |
1,109,056 |
520,453 |
| Coric Vlad | Director |
Feb 05 '26 |
Buy |
17.00 |
117,646 |
1,999,982 |
319,398 |
| CHILDS JOHN W | Director |
Feb 05 '26 |
Buy |
17.00 |
294,117 |
4,999,989 |
2,202,006 |
| Longitude Capital Partners V, | 10% Owner |
Feb 05 '26 |
Buy |
17.00 |
1,075,000 |
18,275,000 |
2,600,399 |
| ENRIGHT PATRICK G | Director |
Feb 05 '26 |
Buy |
17.00 |
1,075,000 |
18,275,000 |
2,600,399 |
2.18%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):